The development of hepatolocellular carcinoma is not predicted by genetic variants in caucasian compensated HBV cirrhotics treated by Entecavir or Tenofovir for 10 years. (February 2019)

Record Type:
Journal Article
Title:
The development of hepatolocellular carcinoma is not predicted by genetic variants in caucasian compensated HBV cirrhotics treated by Entecavir or Tenofovir for 10 years. (February 2019)
Main Title:
The development of hepatolocellular carcinoma is not predicted by genetic variants in caucasian compensated HBV cirrhotics treated by Entecavir or Tenofovir for 10 years
Authors:
Loglio, A.
Galmozzi, E.
Iavarone, M.
Facchetti, F.
Viganò, M.
Perbellini, R.
Segato, S.
Filippi, E.
Rumi, M.G.
Sangiovanni, A.
Lampertico, P.
Abstract:
Is Part Of:
Digestive and liver disease. Volume 51(2019)Supplement 1
Journal:
Digestive and liver disease
Issue:
Volume 51(2019)Supplement 1
Issue Display:
Volume 51, Issue 1 (2019)
Year:
2019
Volume:
51
Issue:
1
Issue Sort Value:
2019-0051-0001-0000
Page Start:
e56
Page End:
Publication Date:
2019-02
Subjects:
Digestive organs -- Diseases -- Periodicals
Liver -- Diseases -- Periodicals
616.33005
Journal URLs:
http://www.sciencedirect.com/science/journal/15908658 ↗
http://www.elsevier.com/journals ↗
DOI:
10.1016/j.dld.2018.11.142 ↗
Languages:
English
ISSNs:
1590-8658
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 3588.345600
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
9591.xml